Evan Rachlin
Evan Rachlin is co-founder and Managing Partner of Ascenta Capital, previously at Blackstone Life Sciences, Moderna, Bain Capital Ventures, McKinsey, and Pfizer. He holds degrees from Harvard University and Harvard Medical School.
What Evan can write
Ascenta Capital writes $10M to $30M checks, larger than 97% of firms in the atlas.
Bars: how many firms report each check band. Highlighted: Ascenta Capital.Career
- McKinsey & Company
- Pfizer
- Bain Capital Ventures · Principal2012-2015
- Moderna · Head of Strategy2015-2019
- Blackstone Life Sciences · Managing Director2019-2022
- Ascenta Capital · Co-Founder and Managing PartnerNow
- McKinsey & Company
- Pfizer
Companies founded
Investments named in public bios
Focus
Education
Also at Ascenta Capital
Alert me when Ascenta Capital is active
One email when Evan's firm raises a fund, adds a partner or shows new activity.
Send Mode VC your deck
Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckQuestions
Who is Evan Rachlin?
Evan Rachlin is co-founder and Managing Partner of Ascenta Capital, previously at Blackstone Life Sciences, Moderna, Bain Capital Ventures, McKinsey, and Pfizer. He holds degrees from Harvard University and Harvard Medical School.
How much does Evan Rachlin invest?
Evan Rachlin invests through Ascenta Capital, which writes checks of $10M to $30M.
How do I pitch Evan Rachlin?
Email [email protected], the firm's inbox for founders, and name Evan in the subject. A warm intro from a founder Ascenta Capital backed works better.
What did Evan Rachlin do before Ascenta Capital?
McKinsey & Company; Pfizer; Principal at Bain Capital Ventures; Head of Strategy at Moderna; Managing Director at Blackstone Life Sciences; McKinsey & Company; Pfizer.
Last updated 2026-10-15. Is this you? Ask for a correction.